Massbank MS database records for Chlorcyclizine
| Massbank ID | Instrument | Inst. type | Collision energy | Ion type | Ion mode | MS level |
|---|---|---|---|---|---|---|
| MSBNK-Eawag-EQ347607 | Q Exactive Plus Orbitrap Therm... | LC-ESI-QFT | 120 (nominal) | [M+H]+ | POSITIVE | MS2 |
| MSBNK-Eawag-EQ347608 | Q Exactive Plus Orbitrap Therm... | LC-ESI-QFT | 150 (nominal) | [M+H]+ | POSITIVE | MS2 |
| MSBNK-Eawag_Additional_Specs-ET010001 | Q Exactive Orbitrap Thermo Sci... | LC-ESI-QFT | 15, 30, 45, 60, 70 or 90 (nominal) | [M+H]+ | POSITIVE | MS2 |
| MSBNK-Eawag_Additional_Specs-ET010002 | Q Exactive Orbitrap Thermo Sci... | LC-ESI-QFT | 15, 30, 45, 60, 70 or 90 (nominal) | [M+H]+ | POSITIVE | MS2 |
| MSBNK-Eawag_Additional_Specs-ET010003 | Q Exactive Orbitrap Thermo Sci... | LC-ESI-QFT | 15, 30, 45, 60, 70 or 90 (nominal) | [M+H]+ | POSITIVE | MS2 |
| MSBNK-Eawag_Additional_Specs-ET010004 | Q Exactive Orbitrap Thermo Sci... | LC-ESI-QFT | 15, 30, 45, 60, 70 or 90 (nominal) | [M+H]+ | POSITIVE | MS2 |
| MSBNK-Eawag_Additional_Specs-ET010005 | Q Exactive Orbitrap Thermo Sci... | LC-ESI-QFT | 15, 30, 45, 60, 70 or 90 (nominal) | [M+H]+ | POSITIVE | MS2 |
| MSBNK-Eawag-EQ347601 | Q Exactive Plus Orbitrap Therm... | LC-ESI-QFT | 15 (nominal) | [M+H]+ | POSITIVE | MS2 |
| MSBNK-Eawag-EQ347609 | Q Exactive Plus Orbitrap Therm... | LC-ESI-QFT | 180 (nominal) | [M+H]+ | POSITIVE | MS2 |
| MSBNK-Eawag-EQ347602 | Q Exactive Plus Orbitrap Therm... | LC-ESI-QFT | 30 (nominal) | [M+H]+ | POSITIVE | MS2 |
| MSBNK-Eawag-EQ347603 | Q Exactive Plus Orbitrap Therm... | LC-ESI-QFT | 45 (nominal) | [M+H]+ | POSITIVE | MS2 |
| MSBNK-Eawag-EQ347604 | Q Exactive Plus Orbitrap Therm... | LC-ESI-QFT | 60 (nominal) | [M+H]+ | POSITIVE | MS2 |
| MSBNK-Eawag-EQ347605 | Q Exactive Plus Orbitrap Therm... | LC-ESI-QFT | 75 (nominal) | [M+H]+ | POSITIVE | MS2 |
| MSBNK-Eawag-EQ347606 | Q Exactive Plus Orbitrap Therm... | LC-ESI-QFT | 90 (nominal) | [M+H]+ | POSITIVE | MS2 |
| MSBNK-Fac_Eng_Univ_Tokyo-JP003068 | Unknown | EI-B | - | - | POSITIVE | MS |